Edition:
United States

Aradigm Corp (ARDM.OQ)

ARDM.OQ on NASDAQ Stock Exchange Capital Market

1.45USD
18 May 2018
Change (% chg)

$0.03 (+2.11%)
Prev Close
$1.42
Open
$1.41
Day's High
$1.53
Day's Low
$1.41
Volume
3,631
Avg. Vol
47,320
52-wk High
$7.26
52-wk Low
$1.00

Summary

Name Age Since Current Position

John Siebert

77 2018 Executive Chairman of the Board, Interim Principal Executive Officer, Acting Principal Financial Officer

Edwin Gordon

63 2018 Director

Frederick Hudson

71 2014 Independent Director

Biographies

Name Description

John Siebert

Dr. John M. Siebert Ph.D. is Executive Chairman of the Board, Interim Principal Executive Officer, Acting Principal Financial Officer of the Company. Dr. Siebert is Founder and Chief Executive Officer of Compan Pharmaceuticals, Inc., a companion animal pharmaceutical company. From May 2014 to November 2015, Dr. Siebert was Chief Executive Officer of Chase Pharmaceuticals, a company conducting clinical trials in Alzheimer’s disease. From 2010 to 2014, he was a Partner and Chief Operating Officer of New Rhein Healthcare Investors, LLC, a private equity group. From May 2003 to October 2008, Dr. Siebert was the Chairman and Chief Executive Officer of CyDex, Inc., a privately held specialty pharmaceutical company. From September 1995 to April 2003, he was President and Chief Executive Officer of CIMA Labs Inc., a publicly traded drug delivery company, and from July 1995 to September 1995 he was President and Chief Operating Officer of CIMA Labs Inc. From 1992 to 1995, Dr. Siebert was Vice President, Technical Affairs at Dey Laboratories, Inc., a privately held pharmaceutical company. From 1988 to 1992, he headed R&D and Quality Control at a division of Bayer Corporation. Prior to that, Dr. Siebert was employed by E.R. Squibb & Sons, Inc., G.D. Searle & Co., Gillette and The Procter & Gamble Company. Dr. Siebert holds a B.S. in Chemistry from Illinois Benedictine University, an M.S. in Organic Chemistry from Wichita State University and a Ph.D. in Organic Chemistry from the University of Missouri. Dr. Siebert also serves on the board of directors of Supernus Pharmaceuticals, Inc., which he joined in January 2011. On the Supernus Pharmaceuticals, Inc. board of directors, Dr. Siebert is a member of the Audit Committee and the Compensation Committee.

Edwin Gordon

Mr. Edwin Gordon is Director of the Company. He is the founder and principal of 4C Advisors, LLC, an advisory firm rendering differentiated financing, transactional and advisory services to life sciences companies. From 2012 to 2017, Mr. Gordon served as a managing director of the Health Care Investment Banking group of Ladenburg Thalmann & Co. Inc. (“Ladenburg”), a firm providing investment banking services to life sciences and other companies and a subsidiary of Ladenburg Thalmann Financial Services Inc. From 2008 to 2012, he was a managing director and head of the Health Care Investment Banking group of Ladenburg. Throughout his tenure at Ladenburg, Mr. Gordon was a member of the firm’s Equity Commitment Committee. Previously, Mr. Gordon served as a Managing Director in the health care banking groups of Merriman Curhan Ford & Co., Punk, Ziegel & Co., L.P., Cowen & Co., and Furman Selz. Prior to his career in investment banking, Mr. Gordon served as the senior Health Care Services Equity Analyst at Morgan Stanley & Co., Tucker Anthony & Day, and Prudential Bache Securities, covering hospital management, health insurance, and physician practices management companies on behalf of those firms’ institutional equity businesses. Mr. Gordon holds a BA in economics and an MBA in finance from the University of Pittsburgh.

Frederick Hudson

Mr. Frederick M. Hudson CPA is Independent Director of the Company. He retired as a partner in charge of the health care audit practice for the Washington-Baltimore business unit of the accounting firm of KPMG, LLP on January 1, 2006 after a 37-year career with the firm. Mr. Hudson is currently a director and audit committee chair of Supernus Pharmaceuticals, Inc. and a director and compliance committee member of Maxim Health Care Services, Inc. He also has recently served in a board capacity with the Board of Financial Administration of the Catholic Archdiocese of Baltimore, with the Board of Trustees of the Maryland Historical Society, and as director and audit committee chair of Educate, Inc. He is vice-chair and finance committee chair of the Board of Directors of GBMC Healthcare, Inc. and its affiliate, Greater Baltimore Medical Center. Mr. Hudson received a B.S. in Accounting from Loyola University Maryland and is a Certified Public Accountant. We believe that Mr. Hudson’s extensive accounting and health care audit experience qualify him to serve as a member of our board of directors.

Basic Compensation

Name Fiscal Year Total

John Siebert

--

Edwin Gordon

--

Frederick Hudson

--
As Of 

Options Compensation

Name Options Value

John Siebert

0 0

Edwin Gordon

0 0

Frederick Hudson

0 0